Amit Shah to kick off BJP's poll campaign in Karnataka with yatra

Kasaragod, April 9: After Supreme Court intervened and settled the Border issue with Karnataka authorities who had consented to allow the critically-ill patients from in and around Kasaragod and nearby areas to cross over to nearby Mangalore for getting urgent and critical care treatment, the Karnataka authorities is alleged to continue to be hostile either by blocking way ahead or turning a deaf ear to the patients reaching there.

It was on Wednesday onwards that the check post at Thalapadi near here on the Kozhikode-Mangalore National Highway was opened for the critically-ill patients to cross over to Mangalore hospitals for medical treatment.

However, reports reaching here said two out of the three critically-ill patients, who made it to Mangalore were allegedly ill-treated or given no treatment forcing them to return back to Kerala.

Bengaluru, Jul 5: A 50-year-old woman with breathing difficulties died on Saturday after a shortage of beds forced 12 hospitals to refuse admission.

Her husband Babu said the family had approached 12 hospitals in three days, including Victoria Hospital and other private facilities, who all slammed their doors on them, citing a shortage of beds. The woman died on Saturday, a few minutes into her admission at KC General Hospital.

Second death 

A 35-year-old man, Manjunath, also died on Saturday after enduring fever for three days and being refused admission at several hospitals due to a shortage of beds.

As his condition worsened, his wife admitted him to a private hospital on Saturday after hours of ordeal. But the man died less than 15 minutes after getting admitted. Hospital authorities took swab samples from the deceased and said the body would be handed over after the test results.

BBMP personnel also failed to shift the body of a Covid-19 patient in Kalasipalya almost a day after the death.

Despite civic workers disinfecting the place, the neighbours were in a state of panic after the body was kept at home.

Washington, May 19: As the scientists across the world are struggling to develop a vaccine for combating coronavirus, US drugmaker Moderna announced on Monday (local time) that the phase I trial of its Covid-19 vaccine has shown positive early results.

The company is hopeful that it's vaccine could be available to the public as early as January next year. Several firms across the world are in the race to develop a vaccine for the deadly virus which has claimed over 3 lakh lives worldwide.

CNN citing Dr. Tal Zaks, Moderna's chief medical officer reported that "if future studies go well, the company's vaccine could be available to the public as early as January".

"This is absolutely good news and news that we think many have been waiting for for quite some time," Zaks was quoted as saying.

Moderna, based in Cambridge, Massachusetts announced that the vaccine developed neutralising antibodies to the virus at levels reaching or exceeding the levels seen in people who have naturally recovered from Covid-19, reported CNN.

These will be followed by phase 2 trials and phase 3 trials, which Moderna plans to start in July.

President Donald Trump had on Friday said that that the United States will be able to deliver a few hundred million doses of COVID-19 vaccine, under 'Operation Warp Speed', by the end of this year.

"I have very recently seen early data from a clinical trial with a coronavirus vaccine and this data made me feel even more confident that we'll be able to deliver a few hundred million doses of vaccine by the end of 2020 and we will do the best we can," Trump had said at a press conference at the White House on Friday.